Microdosing LSD for Alzheimer’s proves safe in early human trial

Posted in Medicine on 20th Dec, 2019
by Alex Muller

New results have been published from one of the first placebo-controlled clinical trials investigating the effects of microdosing LSD. This Phase 1 trial is the first step in testing whether these kinds of psychedelic microdose methods could be useful as a therapeutic approach for treating Alzheimer’s disease

Scientists edit addiction memories with ketamine to treat alcoholism

Posted in Highlights from UCL, Medicine on 27th Nov, 2019
by Alex Muller

An incredible new experimental study from University College London has found a specifically timed infusion of ketamine can effectively rewrite reward memories

Brainwave study reveals psychedelic DMT produces "waking-dream" state

Posted in Science on 20th Nov, 2019
by Alex Muller

The new research from Imperial College London capitalized on the short-acting nature of DMT to conduct a temporal investigation into how the drug alters a person’s brain activity across a 20-minute experience.

Microbiome-altering Alzheimer’s drug unexpectedly approved in China

Posted in Medicine on 6th Nov, 2019
by Alex Muller

The drug, derived from a marine algae, is the first new Alzheimer’s drug to reach the market anywhere in the world in almost 20 years, and is suggested to reduce neuroinflammation by modulating a person’s gut microbiome.

Scientists Found New Antibiotic Molecules, Right In the Human Microbiome

Posted in Medicine on 21st Oct, 2019
by Alex Muller

We’re looking at “an unprecedented resource for drug discovery from within the human body,”